Impact of Reference and Target Region Selection on Amyloid PET SUV Ratios in the Phase 1b PRIME Study of Aducanumab.
J Nucl Med
; 60(1): 100-106, 2019 01.
Article
in En
| MEDLINE
| ID: mdl-29777003
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Positron-Emission Tomography
/
Antibodies, Monoclonal, Humanized
/
Amyloid
Type of study:
Clinical_trials
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
En
Journal:
J Nucl Med
Year:
2019
Document type:
Article
Country of publication: